login
Primeiro acesso? Clique aqui

Este site foi desenvolvido com tecnologias avançadas para
lhe proporcionar uma experiência incrível.
Infelizmente, este navegador não é suportado

Sugerimos que você use o
Google Chrome para melhores resultados.

Febre Amarela

17 de janeiro de 2017

febre_amarela_grande

Em Minas Gerais  25 municípios enfrentam o último surto de febre amarela silvestre desde o início do ano. A Biblioteca Virtual da AMMG selecionou os principais artigos sobre o tema. Confira:

 

 

 

 

 

 

 

Identification and initial characterization of matrix metalloproteinases in the yellow fever mosquito, Aedes aegypti.

Kantor AM, Dong S, Held NL, Ishimwe E, Passarelli AL, Clem RJ, Franz AW.

Insect Mol Biol. 2017 Feb;26(1):113-126. doi: 10.1111/imb.12275.

PMID: 28054419

A Yellow Fever Epidemic: A New Global Health Emergency?

Lucey D, Gostin LO.

JAMA. 2016 Jun 28;315(24):2661-2. doi: 10.1001/jama.2016.6606. No abstract available.

PMID: 27158803

Características epidemiológicas da febre amarela no Brasil, 2000-2012.

Cavalcante KR, Tauil PL.

Epidemiol Serv Saude. 2016 Jan-Mar;25(1):11-20. doi: 10.5123/S1679-49742016000100002. English, Portuguese.

PMID: 27861674

Yellow Fever Remains a Potential Threat to Public Health.

Vasconcelos PF, Monath TP.

Vector Borne Zoonotic Dis. 2016 Aug;16(8):566-7. doi: 10.1089/vbz.2016.2031.

PMID: 27400066

Climate Change and the Arboviruses: Lessons from the Evolution of the Dengue and Yellow Fever Viruses.

Tabachnick WJ.

Annu Rev Virol. 2016 Sep 29;3(1):125-145.

PMID: 27482902

Yellow fever vaccination - Once in a lifetime?

Travel Med Infect Dis. 2016 Dec 21. pii: S1477-8939(16)30210-1. doi: 10.1016/j.tmaid.2016.12.003. [Epub ahead of print] No abstract available.

PMID: 28013052

Fractional dosing of yellow fever vaccine to extend supply: a modelling study.

Wu JT, Peak CM, Leung GM, Lipsitch M.

Lancet. 2016 Dec 10;388(10062):2904-2911. doi: 10.1016/S0140-6736(16)31838-4.

PMID: 27837923

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.

Wieten RW, Jonker EF, van Leeuwen EM, Remmerswaal EB, Ten Berge IJ, de Visser AW, van Genderen PJ, Goorhuis A, Visser LG, Grobusch MP, de Bree GJ.

PLoS One. 2016 Mar 15;11(3):e0149871. doi: 10.1371/journal.pone.0149871.

PMID: 26977808

Booster dose after 10 years is recommended following 17DD-YF primary vaccination.

Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, et. al.

Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693.

PMID: 26360663

Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.

Fernandez-Garcia MD, Meertens L, Chazal M, Hafirassou ML, Dejarnac O, Zamborlini A, Despres P, Sauvonnet N, Arenzana-Seisdedos F, Jouvenet N, Amara A.

MBio. 2016 Feb 9;7(1):e01956-15. doi: 10.1128/mBio.01956-15.

PMID: 26861019

A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination.

Jean K, Donnelly CA, Ferguson NM, Garske T.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1435-1439.

PMID: 27928091

The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.

Watson AM, Lam LK, Klimstra WB, Ryman KD.

PLoS Pathog. 2016 Jul 27;12(7):e1005786. doi: 10.1371/journal.ppat.1005786.

PMID: 27463517

Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Amanna IJ, Slifka MK.

Expert Rev Vaccines. 2016 Dec;15(12):1519-1533.

PMID: 27267203

Yellow fever vaccine-associated viscerotropic disease: current perspectives.

Thomas RE.

Drug Des Devel Ther. 2016 Oct 12;10:3345-3353. Review.

PMID: 27784992

Adverse event reports following yellow fever vaccination, 2007-13.

Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE.

J Travel Med. 2016 Jul 4;23(5). pii: taw045. doi: 10.1093/jtm/taw045.

PMID: 27378369

Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.

Wieten RW, Jonker EF, Pieren DK, Hodiamont CJ, van Thiel PP, van Gorp EC, de Visser AW, Grobusch MP, Visser LG, Goorhuis A.

Vaccine. 2016 Mar 4;34(10):1247-51. doi: 10.1016/j.vaccine.2016.01.037.

PMID: 26845742

Yellow fever.

Monath TP, Vasconcelos PF.

J Clin Virol. 2015 Mar;64:160-73. doi: 10.1016/j.jcv.2014.08.030. Review.

PMID: 25453327